Catalyze Capital | Activity | F4

Team Portfolio Raise Champions Essays

F4/Catalyze Capital/Activity

Catalyze Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Invested in Breye Therapeutics to advance oral treatments for retinal diseases.

Breye Therapeutics

Breye Therapeutics Catalyze Capital

catalyze-capital.comSEP 29, 2026

SEP 29, 2026

Investment

Invested in Melt&Marble to scale precision-fermentation fats.

Melt & Marble

Melt & Marble Catalyze Capital

catalyze-capital.comDEC 8, 2025

DEC 8, 2025

Milestone

Portfolio company Neuro Event Labs received FDA 510(k) clearance.

Neuro Event Labs

Neuro Event Labs Catalyze Capital

catalyze-capital.comNOV 26, 2025

NOV 26, 2025

Investment

Participated in Gesynta Pharma's SEK 304M Series B for its endometriosis drug candidate.

Gesynta Pharma

Gesynta Pharma Catalyze Capital

catalyze-capital.comJAN 20, 2025

JAN 20, 2025